estrone has been researched along with fadrozole in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (75.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aupetit, B; Bhatnagar, AS; Ezzet, F; Girard, F; Menard, J; Mueller, P; Trunet, PF; Zognbi, F | 1 |
Demers, LM; Garber, JE; Hanagan, J; Harvey, H; Henderson, IC; Lipton, A; Lynch, J; Mulagha, M; Navari, RM; Santen, RJ | 1 |
Dowsett, M; Haynes, B; Jacobs, S; Jones, A; Lønning, PE; Powles, T | 1 |
Horiuchi, R; Iino, Y; Maemura, M; Morishita, Y; Owada, S; Sato, H; Sugamata, N; Tago, T; Yokoe, T | 1 |
Coombes, RC; Dowsett, M; Mehta, A; Stein, RC | 1 |
Klepp, R; Kvinnsland, S; Lønning, PE | 1 |
Hayashi, K; Kosaki, G; Shimozuma, K; Tominaga, T; Yoshida, Y | 1 |
Demers, L; Entwistle, EA; Kochak, GM; Lipton, A; Mangat, S; Mulagha, MT; Santen, RJ | 1 |
Beretta, KR; Bhatnagar, AS; Cavalli, F; Chaudri, HA; Goldhirsch, A; Hoeffken, K; Kvinnsland, S; Trunet, P | 1 |
Coombes, RC; Dowsett, M; Moore, J; Powles, TJ; Rubens, R; Smith, IE; Smithers, D; Trunet, PF | 1 |
Demers, LM | 1 |
Arnold, AP; Hodges, L; Schlinger, BA; Wade, J | 1 |
Abe, O; Koyama, H; Nomura, Y; Oohashi, Y; Takashima, S; Wada, T | 1 |
Bhatnagar, AS; King, EJ; Purba, HS; Richert, P | 1 |
Demers, LM; Hanagan, J; Harvey, HA; Lipton, A; Mulagha, M; Santen, RJ | 1 |
Fusani, L; Gahr, M; Hutchison, JB | 1 |
Adachi, I; Ikeda, T; Ohashi, Y; Sasaki, Y; Suwa, T; Tabei, T; Takatsuka, Y; Toi, M; Tominaga, T | 1 |
Calis, K; Cutler, GB; Feuillan, PP; Jones, J; Nunez, SB | 1 |
Hori, H; Kagawa, N; Waterman, MR; Yoshioka, S | 1 |
Yahr, P | 1 |
8 trial(s) available for estrone and fadrozole
Article | Year |
---|---|
The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects.
Topics: Adult; Aldosterone; Cosyntropin; Desoxycorticosterone; Double-Blind Method; Estradiol; Estrogen Antagonists; Estrone; Fadrozole; Furosemide; Humans; Hydrocortisone; Imidazoles; Nitriles; Posture; Reference Values; Renin | 1992 |
Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Fadrozole; Female; Gonadal Steroid Hormones; Humans; Imidazoles; Menopause; Middle Aged; Neoplasm Metastasis; Nitriles; Randomized Controlled Trials as Topic | 1990 |
CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I study.
Topics: Adult; Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Imidazoles; Middle Aged; Nitriles; Remission Induction | 1990 |
Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogens; Estrone; Fadrozole; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause | 1994 |
Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients.
Topics: Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogens; Estrone; Fadrozole; Female; Humans; Letrozole; Middle Aged; Nitriles; Radioimmunoassay; Triazoles | 1994 |
[Late phase II study of CGS16949A, a new aromatase inhibitor--a multicentral cooperative study (Western Japan Group)].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Estradiol; Estrone; Fadrozole; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Postmenopause | 1994 |
The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Neoplasm Staging | 1993 |
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
Topics: Administration, Oral; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrone; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Safety; Survival Rate; Triazoles | 2003 |
12 other study(ies) available for estrone and fadrozole
Article | Year |
---|---|
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Kinetics; Menopause; Nitriles | 1991 |
The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.
Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Estrone; Fadrozole; Female; Humans; Imidazoles; Middle Aged; Nitriles | 1991 |
Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Estradiol; Estrone; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estrogen; Testosterone; Uterus | 1991 |
Plasma estrone and estrone sulphate in breast cancer patients treated with the aromatase inhibitor CGS 16949A.
Topics: Aged; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estrone; Fadrozole; Humans; Imidazoles; Male; Middle Aged; Nitriles; Time Factors | 1990 |
Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrone; Fadrozole; Female; Follicle Stimulating Hormone; Imidazoles; Luteinizing Hormone; Mammary Neoplasms, Experimental; Nitriles; Prolactin; Rats; Rats, Inbred Strains; Tamoxifen | 1990 |
The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition.
Topics: Aged; Aromatase Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation; Estradiol; Estrogens; Estrone; Fadrozole; Female; Humans; Imidazoles; Metabolic Clearance Rate; Middle Aged; Nitriles; Testosterone | 1990 |
Fadrozole: a potent and specific inhibitor of aromatase in the zebra finch brain.
Topics: Androstatrienes; Animals; Aromatase Inhibitors; Birds; Brain; Cells, Cultured; Estradiol; Estrone; Fadrozole; Oxidoreductases; Telencephalon; Testosterone | 1994 |
Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Binding, Competitive; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estradiol; Estrone; Fadrozole; Female; Ketoconazole; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Steroid Hydroxylases; Substrate Specificity | 1994 |
Aromatase inhibition reduces specifically one display of the ring dove courtship behavior.
Topics: Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Columbidae; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrogens; Estrone; Fadrozole; Male; Sexual Behavior, Animal; Testosterone | 2001 |
Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
Topics: Age Determination by Skeleton; Aging; Aromatase Inhibitors; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Estradiol; Estrone; Fadrozole; Female; Fibrous Dysplasia, Polyostotic; Gonadotropin-Releasing Hormone; Growth; Humans; Menstruation; Ovary; Puberty, Precocious; Treatment Failure; Triptorelin Pamoate; Ultrasonography | 2003 |
Characterization of stable human aromatase expressed in E. coli.
Topics: Amino Acid Sequence; Androstenedione; Arginine; Aromatase; Aromatase Inhibitors; Cell Membrane; Chaperonin 10; Chaperonin 60; Chloramphenicol; Cysteine; Electron Spin Resonance Spectroscopy; Enzyme Stability; Escherichia coli; Estradiol; Estrone; Fadrozole; Gene Expression; Humans; Letrozole; Molecular Sequence Data; Nitriles; Polymorphism, Genetic; Protein Structure, Secondary; Protein Synthesis Inhibitors; Recombinant Proteins; Solubility; Testosterone; Triazoles | 2004 |
Two aromatase inhibitors inhibit the ability of a third to promote mating in male rats.
Topics: Androgens; Androstatrienes; Androstenedione; Animals; Aromatase Inhibitors; Drug Interactions; Estradiol; Estrone; Fadrozole; Female; Male; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reproduction; Sexual Behavior, Animal; Testosterone | 2015 |